Sanofi India Limited (SANOFI) - Net Assets

Latest as of December 2025: Rs7.49 Billion INR ≈ $81.02 Million USD

Based on the latest financial reports, Sanofi India Limited (SANOFI) has net assets worth Rs7.49 Billion INR (≈ $81.02 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs12.55 Billion ≈ $135.70 Million USD) and total liabilities (Rs5.06 Billion ≈ $54.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SANOFI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs7.49 Billion
% of Total Assets	59.71%
Annual Growth Rate	2.77%
5-Year Change	-66.34%
10-Year Change	-56.83%
Growth Volatility	15.62

Sanofi India Limited - Net Assets Trend (2004–2025)

This chart illustrates how Sanofi India Limited's net assets have evolved over time, based on quarterly financial data. Also explore Sanofi India Limited balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Sanofi India Limited (2004–2025)

The table below shows the annual net assets of Sanofi India Limited from 2004 to 2025. For live valuation and market cap data, see Sanofi India Limited market cap and net worth.

Year	Net Assets	Change
2025-12-31	Rs7.49 Billion ≈ $81.02 Million	-12.94%
2024-12-31	Rs8.61 Billion ≈ $93.07 Million	-15.23%
2023-12-31	Rs10.15 Billion ≈ $109.79 Million	-20.43%
2022-12-31	Rs12.76 Billion ≈ $137.97 Million	-42.68%
2021-12-31	Rs22.26 Billion ≈ $240.69 Million	+5.03%
2020-12-31	Rs21.19 Billion ≈ $229.16 Million	-13.24%
2019-12-31	Rs24.42 Billion ≈ $264.13 Million	+10.05%
2018-12-31	Rs22.19 Billion ≈ $240.00 Million	+9.51%
2017-12-31	Rs20.26 Billion ≈ $219.15 Million	+16.76%
2016-12-31	Rs17.36 Billion ≈ $187.70 Million	+6.66%
2015-12-31	Rs16.27 Billion ≈ $175.97 Million	+9.51%
2014-12-31	Rs14.86 Billion ≈ $160.69 Million	+10.33%
2013-12-31	Rs13.47 Billion ≈ $145.64 Million	+11.84%
2012-12-31	Rs12.04 Billion ≈ $130.22 Million	+7.84%
2011-12-31	Rs11.17 Billion ≈ $120.76 Million	+10.10%
2010-12-31	Rs10.14 Billion ≈ $109.68 Million	+8.84%
2009-12-31	Rs9.32 Billion ≈ $100.77 Million	+12.39%
2008-12-31	Rs8.29 Billion ≈ $89.66 Million	+17.30%
2007-12-31	Rs7.07 Billion ≈ $76.44 Million	+16.22%
2006-12-31	Rs6.08 Billion ≈ $65.78 Million	+16.12%
2005-12-31	Rs5.24 Billion ≈ $56.65 Million	+24.17%
2004-12-31	Rs4.22 Billion ≈ $45.62 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sanofi India Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Rs230.00 Million	3.07%
Other Components	Rs7.26 Billion	96.93%
Total Equity	Rs7.49 Billion	100.00%

Sanofi India Limited Competitors by Market Cap

The table below lists competitors of Sanofi India Limited ranked by their market capitalization.

Company	Market Cap
Ams AG SW:AMS	$848.87 Million
Xinjiang Yilite Industry Co Ltd SHG:600197	$848.89 Million
Chongqing Constr Engineering SHG:600939	$849.10 Million
Crystal Growth & Energy Equipment Co. Ltd. A SHG:688478	$849.17 Million
Ningbo Tech-Bank Co Ltd SHE:002124	$848.61 Million
Power Mech Projects Limited NSE:POWERMECH	$848.57 Million
Jiangsu Rainbow Heavy Industries Co Ltd SHE:002483	$848.36 Million
Zhejiang Chunhui Intelligent Control Co. Ltd. SHE:300943	$848.23 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sanofi India Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 8,606,000,000 to 7,492,000,000, a change of -1,114,000,000 (-12.9%).
Net income of 3,267,000,000 contributed positively to equity growth.
Dividend payments of 4,422,000,000 reduced retained earnings.
Other comprehensive income decreased equity by 3,898,000,000.
Other factors increased equity by 3,939,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs3.27 Billion	+43.61%
Dividends Paid	Rs4.42 Billion	-59.02%
Other Comprehensive Income	Rs-3.90 Billion	-52.03%
Other Changes	Rs3.94 Billion	+52.58%
Total Change	Rs-	-12.94%

Book Value vs Market Value Analysis

This analysis compares Sanofi India Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 10.47x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 18.60x to 10.47x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2004-12-31	Rs183.16	Rs3407.20	x
2005-12-31	Rs227.43	Rs3407.20	x
2006-12-31	Rs264.08	Rs3407.20	x
2007-12-31	Rs306.91	Rs3407.20	x
2008-12-31	Rs360.00	Rs3407.20	x
2009-12-31	Rs404.59	Rs3407.20	x
2010-12-31	Rs440.35	Rs3407.20	x
2011-12-31	Rs484.84	Rs3407.20	x
2012-12-31	Rs522.83	Rs3407.20	x
2013-12-31	Rs584.74	Rs3407.20	x
2014-12-31	Rs645.16	Rs3407.20	x
2015-12-31	Rs706.52	Rs3407.20	x
2016-12-31	Rs753.61	Rs3407.20	x
2017-12-31	Rs879.87	Rs3407.20	x
2018-12-31	Rs963.59	Rs3407.20	x
2019-12-31	Rs1060.46	Rs3407.20	x
2020-12-31	Rs920.08	Rs3407.20	x
2021-12-31	Rs966.37	Rs3407.20	x
2022-12-31	Rs553.96	Rs3407.20	x
2023-12-31	Rs440.80	Rs3407.20	x
2024-12-31	Rs373.68	Rs3407.20	x
2025-12-31	Rs325.30	Rs3407.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sanofi India Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 43.61%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 17.78%
• Asset Turnover: 1.46x
• Equity Multiplier: 1.67x
Recent ROE (43.61%) is above the historical average (26.58%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	35.20%	20.20%	1.29x	1.35x	Rs1.06 Billion
2005	27.70%	17.96%	1.16x	1.33x	Rs927.05 Million
2006	27.83%	19.15%	1.03x	1.41x	Rs1.08 Billion
2007	20.43%	16.53%	0.95x	1.30x	Rs737.39 Million
2008	20.05%	16.90%	0.92x	1.28x	Rs832.89 Million
2009	16.89%	16.15%	0.81x	1.29x	Rs642.35 Million
2010	15.29%	14.29%	0.77x	1.39x	Rs536.00 Million
2011	17.12%	15.55%	0.82x	1.35x	Rs795.26 Million
2012	14.67%	11.23%	0.96x	1.35x	Rs562.48 Million
2013	19.69%	14.66%	0.98x	1.37x	Rs1.31 Billion
2014	17.74%	13.33%	0.89x	1.50x	Rs1.15 Billion
2015	19.76%	14.66%	0.91x	1.48x	Rs1.59 Billion
2016	17.53%	12.85%	0.93x	1.46x	Rs1.31 Billion
2017	16.09%	13.23%	0.89x	1.37x	Rs1.23 Billion
2018	17.15%	13.74%	0.93x	1.34x	Rs1.59 Billion
2019	16.96%	13.49%	0.95x	1.33x	Rs1.70 Billion
2020	22.54%	16.46%	0.99x	1.38x	Rs2.66 Billion
2021	42.43%	31.94%	0.97x	1.38x	Rs7.22 Billion
2022	48.64%	22.40%	1.34x	1.62x	Rs4.93 Billion
2023	59.39%	30.20%	1.16x	1.69x	Rs5.01 Billion
2024	48.02%	20.53%	1.25x	1.87x	Rs3.27 Billion
2025	43.61%	17.78%	1.46x	1.67x	Rs2.52 Billion

Industry Comparison

This section compares Sanofi India Limited's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

Industry: Drug Manufacturers - General
Average net assets among peers: $11,224,412,515
Average return on equity (ROE) among peers: 25.10%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sanofi India Limited (SANOFI)	Rs7.49 Billion	35.20%	0.67x	$848.62 Million
GlaxoSmithKline Pharmaceuticals Limited (GLAXO)	$21.40 Billion	20.81%	0.83x	$4.28 Billion
NGL Fine-Chem Limited (NGLFINE)	$328.16 Million	25.38%	1.03x	$147.96 Million
Pfizer Limited (PFIZER)	$42.17 Billion	18.20%	0.16x	$2.33 Billion
SANOFI CONS HEALTHC IND L (SANOFICONR)	$2.73 Billion	66.30%	0.58x	$1.19 Billion
SENORES PHARMACEUTICALS L (SENORES)	$94.96 Million	7.21%	0.53x	$447.85 Million
TTK Healthcare Limited (TTKHLTCARE)	$620.96 Million	12.68%	1.22x	$138.16 Million

About Sanofi India Limited

NSE:SANOFI India Drug Manufacturers - General

Market Cap

$848.62 Million

Rs78.47 Billion INR

Market Cap Rank

#9863 Global

#464 in India

Share Price

Rs3407.20

Change (1 day)

-0.81%

52-Week Range

Rs3190.90 - Rs6377.00

All Time High

Rs10072.65